Review of statistical methods for disease mapping by White, Nicole
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
White, Nicole (2012) Review of statistical methods for disease mapping.
(Unpublished)
This file was downloaded from: http://eprints.qut.edu.au/56859/
c© Copyright 2012 Nicole White
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
CRC for Spatial Information
Review of statistical methods for
disease mapping
Prepared by:
Nicole White
for
CRC for Spatial Information
Project 4.42
“Spatio-temporal modelling of
cancer incidence, survival and
mortality”
May 18, 2012
Contents
1 Project description 2
2 Scope of report 3
3 Overview of disease mapping 3
4 Overview of areal data and motivation for the Bayesian approach 6
5 Spatial modelling of disease risk 8
5.1 The Besag, York and Mollie (BYM) model . . . . . . . . . . . . . . . . . . . . . 8
5.2 Alternatives to the BYM model . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
5.2.1 The issue of identifiability . . . . . . . . . . . . . . . . . . . . . . . . . . 11
5.3 Other CAR-based approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
5.4 Clustering-based approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
5.5 Joint modelling of multiple diseases . . . . . . . . . . . . . . . . . . . . . . . . . 16
5.6 Summary of spatial models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
6 Spatio-temporal modelling of disease risk 22
6.1 The BYM model revisited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
6.2 Dynamic linear models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
6.3 Nonparametric approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
6.3.1 Generalised additive mixed models . . . . . . . . . . . . . . . . . . . . . 26
6.3.2 Dirichlet Process Mixture models . . . . . . . . . . . . . . . . . . . . . . 28
6.4 Multiple disease modelling in space and time . . . . . . . . . . . . . . . . . . . . 29
7 Summary of spatio-temporal models 31
8 Contributions to project aims 33
9 Acknowledgements 34
1
1 Project description
Cancer poses an undeniable burden to the health and wellbeing of the Australian community.
In a recent report commissioned by the Australian Institute for Health and Welfare(AIHW,
2010), one in every two Australians on average will be diagnosed with cancer by the age of
85, making cancer the second leading cause of death in 2007, preceded only by cardiovascular
disease.
Despite modest decreases in standardised combined cancer mortality over the past few decades,
in part due to increased funding and access to screening programs, cancer remains a significant
economic burden. In 2010, all cancers accounted for an estimated 19% of the country’s total
burden of disease, equating to approximately $3.8 billion in direct health system costs (Cancer
Council Australia, 2011). Furthermore, there remains established socio-economic and other
demographic inequalities in cancer incidence and survival, for example, by indigenous status
and rurality. Therefore, in the interests of the nation’s health and economic management, there
is an immediate need to devise data-driven strategies to not only understand the socio-economic
drivers of cancer but also facilitate the implementation of cost-effective resource allocation for
cancer management.
The CRC for Spatial Information Project 4.2.2 is a multi-collaborative project that endeavours
to examine and implement innovative statistical methodologies to enhance the analysis, inter-
pretation and management of resources relating to cancer incidence, survival and mortality.
The project consists of partnerships with the Queensland University of Technology, Cancer
Council Queensland, Curtin University of Technology, WA Health, University of Sydney and
the Telethon Institute for Child Health Research (TICHR). Completion of this project is subject
to the fulfilment of the following aims:
1. Development of algorithms for improved estimation and prediction
2. Development of models to link cancer estimates with service location and utilisation
3. Methods for informing health service planning and management
4. Consideration of other disease types
This first aim of this project relates to the review and further development of novel statistical
tools to provide more detailed analyses of cancer mapping over space and time. Examples
of such methodological developments include the incorporation of various risk factors in the
modelling of cancer risk, the integration of different data sources (for example, data collected at
both the point and areal level) and improved projections of cancer incidence based on current
information.
The subsequent two aims relate to the informed allocation of resources for the management
of cancer. In the first instance, models that incorporate information on access to resources
and utilisation patterns will be considered, in an effort to improve estimates of cancer risk.
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Using these results, the intention is to then link these to the development of models that aide
the allocation of cancer resources, such as screening programs. Our focus in this case is on
models that reliably predict the effects of resource allocation and redistribution, striking a
balance between improved cancer outcomes and budgetary constraints. Finally, we envisage
the outcomes of this project will also be applicable to the study of other diseases.
2 Scope of report
The aim of this report is to survey the current literature related to statistical models for disease
mapping. This review commences with a discussion of literature that considers modelling
geographic variation in cancer risk, referred to as disease mapping. Here, we restrict our
attention to models that are suited to areal data only, for reasons relating to data availability
as part of this project. In addition, this report includes discussions on the advantages and
drawbacks of different approaches to disease mapping. Methods for mapping both a single and
multiple diseases simultaneously will be discussed.
In the second half of this report, literature that extends methodology into the time domain
will be reviewed. Upon concluding this review, the implications for successfully addressing the
aims of this project will be outlined.
The intended audience for this report are practitioners in disease mapping, however a pre-
cise understanding of the methodology in this review requires an understanding of Bayesian
statistics. For this reason, practical guidelines for assisting in the choice of different modelling
approaches are also provided in this report.
3 Overview of disease mapping
Disease mapping is the general term given to the modelling of spatial variation is disease risk,
over an area of interest. To initiate this form of study, one is required to define the geographic
scale or resolution for data collection and analysis. In the literature, data collected for disease
mapping is in general categorised as either point level or areal data, both described briefly
here.
At the point level, we consider data collected at a set of locations, say s, which are considered
to vary continuously over the area under study. For example, point level data arises when we
know the geographic locations of individual cases of disease, expressed in terms of latitude and
longitude. For this reason, point level data may also be described as geocoded or geostatistical
data (Banerjee et al., 2004). Given these data, it is often of interest to infer the distribution
of the recorded outcome over the entire region of interest, based only on information collected
on s, and taking spatial correlation into account. This spatial correlation is often measured as
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a function of distance between pairs of locations in s, with measurement aided by Geographic
Information Systems (GIS) technology. While useful for capturing information on individual
cases, the use of point data is not widespread in disease mapping, due to issues surrounding
individual case confidentiality.
Areal data, on the other hand, involves the definition of geographic boundaries, either regular
or irregular, such that individual cases of disease are aggregated based on the regions formed.
A common example of boundary specification is by Statistical Local Area (SLA) (ABS, 2006).
When these region-specific counts are combined with corresponding population estimates, the
resulting information, in the form of a ratio or relative risk, may be conveniently expressed
by a choropleth map, with an example given in Figure 1. This map provides information on
the relative risk of oesophageal cancer incidence among males in Queensland, during the years
1998-2007 (Cramb et al., 2010). In this case, we see a concentration of regions with an elevated
relative risk in the remote, far north of the state, compared to low relative risks in the more
densely populated, urbanised South East corner. Compared to point data, areal data is more
readily available, for example, from census and other government agency databases.
Finally, it is also worth noting a third type of data encountered in practice, known as spatial
point pattern data. Similar to point data, this data involves a set of locations s, indicating
locations of incidence or presence of the outcome of interest. However, from an inferential
perspective, s is now treated as a random quantity, with the aim of analysis being the synthesis
of evidence for spatial clustering of disease. This is in contrast to point level data where s is
assumed fixed.
It follows then that a major implication of disease mapping is the identification of regions with
elevated relative risk or concentrated high risk, which in turn may prompt decisions regarding
resource allocation and targeted disease management. In addition, the inclusion of risk factors,
such as socio-economic status and lifestyle factors, may provide additional information on
discrepancies in risk of outcome among subgroups in the population.
Of course, in practice, a dataset may contain both point and areal data. For example, for anal-
yses involving patient access to resources, utilisation may be measured for each resource present
in the area of interest, resulting in a random variable measured at the point level (in this case
summarised by exact latitude and longitude). Conversely, for the disease under study, inci-
dence rates may only be available at the areal data, resulting in a dataset containing variables
measured at different scale, a problem often referred to as spatial misalignment. Resolutions to
this problem exist (see for example Gelfand et al. (2001) and Banerjee et al. (2004)), but are
not discussed at length here.
In line with the scope of this report, we focus for now on methods suited to the analysis of
areal data.
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Figure 1: Relative risk map for oesophageal cancer incidence among males in Queensland, for
years 1998-2007. Image provided courtesy of Cancer Council Queensland. Relative risks are
coded as Very High (red), High (orange), Average (yellow), Low (light blue) and Very Low
(dark blue).
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4 Overview of areal data and motivation for the Bayesian
approach
Areal data consists of a single or multiple outcomes taken at the regional scale, as defined by
predetermined geographic boundaries. Supposing there are a total of n regions under study,
these data are typically in the form of a count, Yj, for region j = 1, . . . , n. This count may
represent the observed number of cases of disease incidence, mortality or survival.
For non-rare disease, Yj is modelled by a Binomial distribution (Cressie, 1993), namely
Yj|pj ∼ Binom(Nj, pj) (1)
with pj defining the unknown probability of disease outcome and Nj denoting the size of the
population at risk in area j.
Alternatively, for non-contagious and rare disease, each count is generally modelled by a Poisson
distribution
Yj|θj ∼ Po(Ejθj) (2)
where Ej refers to the expected number of cases in region j and θj now representing the associ-
ated unknown relative risk. This change in distributional form is attributed to the relationship
between the Poisson and Binomial distributions, whereby the latter tends to a Poisson distribu-
tion with rate parameter θj = Nj×pj for large Nj and small pj. Marginalisation over θj results
in the unconditional distribution of Yj following a Negative Binomial distribution (Clayton and
Kaldor, 1987).
Given a set of strata, for example gender or age, indexed by k = 1, . . . , K, these expected
counts are computed as follows. For region j
Ej =
K∑
k=1
NjkRk (3)
Yj =
K∑
k=1
Ojk
with Njk denoting the the size of the population at risk in region j and stratum k, Ojk the
observed number of cases and Rk the proportion of cases in stratum k that are expected to
develop the disease. Equation (3) assumes that, for a given stratum, the defined risk is constant
over all regions. The term Rk may be computed in one of two ways. In the first instance, if
these stratum-specific risks are available from external data sources, these may be used as direct
inputs into Equation (3). This is known as external standardisation. Conversely, should this
information not be available, it is possible to approximate each Rk from the observed data,
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aptly referred to as internal standardisation. These estimates take the form:
R̂k =
∑
j Ojk∑
j Njk
.
Both Equations (1) and (2) are examples of a generalized linear model (McCullagh and Nelder,
1989). For the remainder of this review, a Poisson likelihood is assumed, however the ideas
contained within can be easily extended to the Binomial case.
Given the assumed form of the observed data in Equation (2), the likelihood for a sample of n
regions is given by,
(Y1, . . . , Yj, . . . , Yn) ∼
n∏
j=1
Po(Ejθj). (4)
A typical goal of model inference is the estimation of the relative risk for each region. Using
maximum likelihood, this results in the following estimate for each relative risk, known as the
standardised mortality/morbidity ratio (SMR)
θ̂j = YjE
−1
j . (5)
The standard error associated with this estimate is given by
√
Yj/Ej.
In disease mapping studies, the use of statistical inference based on maximum likelihood raises
a number of issues (Mollie´, 1996). Firstly, the above standard error implies that the sampling
variability in the SMR is inversely proportional to the expected number of disease cases in a
given region. In other words, when the expected number of cases is small, as would be the
case in regions with relatively small populations, estimated SMRs will have a high degree of
uncertainty attached to them. Furthermore, this estimate assumes that the expected number
of cases Ej for each region is known, when in fact it is estimated and subject to uncertainty.
The model defined in Equation (4) also assumes the observed disease counts are independently
distributed between regions and thus are assumed spatially uncorrelated. In reality, spatial
independence is rarely a tenable assumption as it is well documented that regions within close
geographic proximity of one another tend to exhibit positively correlated relative risks.
These issues have led authors to instead consider Bayesian approaches to disease mapping.
In essence, Bayesian methods conduct inference based on both information contained in the
likelihood of the observed data and uncertainty about the phenomena via the specification of
prior distributions. Providing an arguably clear advantage over methods based on maximum
likelihood, Bayesian approaches to disease mapping allow for the augmentation of the model to
incorporate a spatial structure of relative risk, resulting in a Bayesian hierarchical model. This
hierarchical structure promotes the concept of Bayesian ‘smoothing’ or ‘borrowing of strength’,
whereby the estimation of relative risk is based upon not only information observed for the
select region but from neighbouring regions as well. Furthermore, hierarchical models allow for
the specification of uncertainty with prior distributions at different levels of the model.
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Given the clear advantages of the Bayesian approach, the remainder of this report seeks to
highlight key Bayesian models proposed for disease mapping. This discussion begins with the
highly-cited model by Besag et al. (1991), who were the first to propose a fully Bayesian analysis
for disease mapping, taking into account the influence of observed risk factors, in addition to
unstructured and spatially structured extra-Poisson variability.
5 Spatial modelling of disease risk
5.1 The Besag, York and Mollie (BYM) model
The seminal paper by Besag et al. (1991), henceforth referred to as the BYM model, was
the first to incorporate spatial smoothing into studies of disease mapping, in a fully Bayesian
framework. This work was an extension of earlier work by Clayton and Kaldor (1987), who
considered the use of Empirical Bayes for the estimation of spatially correlated relative risks
on the logarithmic scale. Their proposal was to model the relative risk of each region by a
combination of fixed and random effects, leading to the specification,
log θj = β
Txj + bj. (6)
As a demonstration of extending Equation (6) to account for the Binomial assumption, high-
lighted in the previous Section, one would express the probability of disease outcome (pj) via
the logit function, yielding
log
(
pj
1− pj
)
= βTxj + bj.
In both cases, the fixed effects β represent a regression on region-specific risk factors or co-
variates xj and the random effects are contained within the term bj. In this context, the
specification of random effects is intended to capture extra-Poisson (or extra-Binomial) vari-
ation not captured by the fixed effects. This unobserved variation may be described either
through a zero-mean Gaussian - bj ∼ N(0, σ2v) - or, taking spatial structure into account,
further decomposed into a sum of terms that do and do not account for spatial structure,
bj = uj + vj. (7)
For the random effects that do not take spatial correlation into accout, these are assigned a
Gaussian with zero mean and common variance,
vj ∼ N(0, σ2v) (8)
or jointly, v ∼ Nn(0, σ2vI). The inclusion of this random effect was intended to account for
any extra-Poisson variability in observed disease counts not attributable to spatial depen-
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dence.
On the topic of spatial dependence, the distribution of each uj may assume one of a number of
forms. In the first instance, these spatial effects may be modelled jointly using a Multivariate
Normal distribution, ie. u ∼ Nn(0, σ2uΣu) where Σu denotes the correlation matrix describing
spatial dependencies between all ui and uj; i 6= j. The key benefit of this prior specification is
its ability to model spatial dependence and ‘borrow strength’ from nearby regions in a smooth,
continuous way. A popular strategy for capturing spatial dependencies between regions via Σu
is to model each element of this correlation matrix as a function of distance. For example, in
Best et al. (2005) and Cook and Pocock (1983), Σu(i,j) = exp(−dijφ), where dij measures the
distance between the (population-weighted) centroids in regions i and j and φ represented a
common parameter describing the overall extent of spatial dependencies present. Other choices
for Σu are discussed in Cressie (1993).
Despite the perceived flexibility of this prior in the joint modelling of u, a critical drawback,
from a model fitting perspective, is the considerable computational cost involved in inverting
Σu and subsequent sampling as part of the Bayesian estimation of these models. As a conse-
quence, this has led authors to devise more efficient prior representations for the spatial random
effects. In Besag et al. (1991), an efficient solution was proposed, whereby spatial dependencies
were modelled via a prespecified neighbourhood structure, defined by the set of conditional
distributions, one for each uj,
uj|ui, i 6= j ∼ N
(∑
iwjiui
nj
,
ω2u
nj
)
(9)
or, equivalently,
uj|u−j ∼ N
(∑
i∼j ui
nj
,
ω2u
nj
)
(10)
where i ∼ j denotes regions i and j sharing a common boundary and u−j denotes the random
effects of all regions excluding region j. This prior is commonly referred to as the intrinsic
conditional autoregressive (CAR) model, with alternative formulations presented in the next
Section. The general CAR specification dates backs to Besag (1974).
To understand this prior, we first require the specification of a neighbourhood matrix, W,
following the notation of Banerjee et al. (2004). With dimension n× n, the diagonal elements
of W corresponding to each region under study are set to 0 and off-diagonal elements wij = 1
if regions i and j share a common boundary and zero otherwise. In this case, a first-order
neighbourhood is defined for each region, with an example given in Figure 2. In this case, the
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Figure 2: Example of an area under study divided up and indexed into regions (N = 9), each
with a select number of “neighbours”.
first-order neighbourhood matrix will be given by
W =

0 1 0 1 0 0 0 0 0
1 0 1 0 1 0 0 0 0
0 1 0 0 0 1 0 0 0
1 0 0 0 1 0 1 0 0
0 1 0 1 0 1 0 1 0
0 0 1 0 1 0 0 0 1
0 0 0 1 0 0 0 1 0
0 0 0 0 1 0 1 0 1
0 0 0 0 0 1 0 1 0

.
Based on this matrix formulation, for region j, nj denotes the number of neighbours, namely
nj =
∑
iwji. The variance term ω
2
u is deliberately defined differently to σ
2
u, as the former
represents a conditional, as opposed to a joint variance.
For more complex models, higher-order neighbourhoods can be defined. For example, the
‘Queen’ neighbourhood configuration (see, for example Earnest et al. (2007)) set wij = 1 if
regions i and j share either a common boundary or vertex. In Earnest et al. (2007), a number of
different neighbourhood matrix specifications were compared by a case study. They concluded
that the choice of neighbourhood matrix results in different levels of smoothing and suggests
guidelines for this choice, depending on the inferential goals of the study.
Jointly, via the use of Brooks’ lemma (Brook, 1964), the prior distribution of u gives rise to a
Gaussian Markov Random Field (GRMF),
u ∼ Nn
(
0,
1
ω2u
(D−W)−1
)
(11)
where D is defined as a diagonal matrix with Djj = nj. Alternative parameterisations of the
featured covariance matrix exist. For example, in Leroux et al. (1999), (D −W) is replaced
with an equivalent neighbourhood matrix R, with elements satisfying
Rij =
{
ni if i = j,
−wij if i 6= j.
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Compared to the joint modelling approach, the conditional nature of the CAR prior in Equation
(10) clearly facilitates more efficient sampling of each uj, as it becomes amenable to Bayesian
methods for model estimation, particularly Markov Chain Monte Carlo (MCMC), and does not
involve the costly step of matrix inversion.
Examining the CAR prior in Equations (10) and (11) further, it is important to note that
(D−W) is singular, meaning that it cannot be inverted. As a result, while the full conditional
for each uj is proper (ie. integrates to a constant), the covariance matrix defining the joint
distribution of u does not exist, resulting in an improper joint prior. An explanation of this
impropriety can be seen by re-expressing Equation (11) as
p(u) ∝ exp
(
− 1
2ω2u
∑
i 6=j
(ui − uj)2
)
(12)
known as the pairwise difference representation. The improper nature of this prior can then be
seen in the following light: should one add a constant (say c) to each element in u, then the
joint probability density p(u) is unaffected. As a result, the elements in u are only uniquely
determined up to a constant. Common remedies to this invariance are either the imposition
of a sum-to-zero constraint on the uj’s, ie.
∑n
j=1 uj = 0 or the exclusion of an intercept from
Equation (6) via the design matrix X. Alternatively, a proper CAR model may be defined
where the neighbourhood matrix W in Equation (11) is multiplied by a constant ρ, chosen to
make (D− ρW) non-singular (Cressie, 1993).
5.2 Alternatives to the BYM model
5.2.1 The issue of identifiability
When coupled with the non-spatial random effects, a notable problem of the BYM model is
that it becomes unidentifiable, with a proof provided in Eberly and Carlin (2000). Essentially,
this issue of identifiability means that, given the observed Yj, one is only capable of making
inferences about the sum of uj+vj, as opposed to inferences about uj and vj individually. When
posterior inferences concerning u and v individually are not of interest, only their identified
sum, the use and estimation of the BYM model is legitimate (Besag et al., 1995). However,
when this is not the case, identifiability becomes a key issue. From a computational perspec-
tive, this lack of identifiability may result in slow convergence. Although the use of informative
priors contributing to these random effects may help alleviate this issue, this specification may
be difficult in practice. In addition, in cases where u and/or v fail to converge as individual
terms (as opposed to their sum), one is unable to separate and assess the degree of excess
variation described by spatial versus unstructured random effects due to slow or lack of conver-
gence for each of these terms (Eberly and Carlin, 2000). For example, in Best et al. (1999), the
proportion of excess variation assigned to clustering in the spatial domain is explored via the
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quantity ψ = SD(u)/(SD(u) + SD(v)), using samples from the relevant stationary distribu-
tions. A comprehensive simulation study exploring these issues is given by Eberly and Carlin
(2000).
To alleviate problems related to identifiability, alternative priors on b have been proposed. In
Leroux et al. (1999), b is instead modelled by the Multivariate Normal prior,
b ∼ Nn (0,Σb)
Σ−1b =
1
σ2b
(λ (Du −W) + (1− λ)In) ,
an approach also adopted by Dean and MacNab (2001) and MacNab (2003). Intuitively, λ ∈
(0, 1) may be interpreted as the proportion of excess Poisson variation explained by spatial
dependencies, and is thus referred to as the spatial autocorrelation parameter. In MacNab
(2011), λ was interpreted as a weight parameter, acting as a trade-off between variation due to
spatial clustering and random, unobserved heterogeneity in risk. This is related to the result
that, as λ = 0, this prior reduces to independent and identically distributed N(0, σ2b ) variates,
indicating no spatial clustering is relative risk. This is in contrast to say, the proper CAR
prior (see previous Section) that, although independent, remains a function of the number of
neighbours for each uj when ρ = 0. Also in its favour, the above joint distribution of b is
proper.
More recently, in a review of GMRF priors in disease mapping studies, MacNab (2011) pro-
posed a so-called convolution prior, representing a trade-off between the intrinsic CAR and
independent Normal priors that also facilitated identifiability of spatial and unstructured ran-
dom effects.
b ∼ Nn(0,Σb)
Σb = λσ
2
b (D−W)−1 + (1− λ)σ2b In
where (D −W)−1 is approximated by its pseudo-inverse. Comparison of this prior with the
BYM model revealed that the parameter λ ∈ (0, 1) was an estimate of the proportion of total
variation explained by spatial structure. The same prior was also used by Ainsworth and
Dean (2006), in an empirical Bayes’ setting. While a simulation study revealed favourable
performance of the convolution prior against the proper CAR and Leroux et al. (1999) priors,
it was noted that, in practice, the proposed prior may not be preferred on the grounds of model
parsimony.
5.3 Other CAR-based approaches
The use of hierarchical models such as the BYM model dominate the disease mapping literature,
yet concerns have been raised regarding their tendency to “oversmooth” region-specific relative
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risk. In particular, the parameters responsible for smoothing these risks, for example σ2b , are
learned from data over all regions and as such, are unable to adapt to discontinuities in risk
between neighbouring regions.
Proposing a variant of the BYM model, Lawson and Clark (2002) focussed on the problem of
modelling spatial variation, balancing between spatial smoothing and modelling large discon-
tinuities in the risk surface. Their approach may be likened to adopting a “mixture of priors”,
in this case an intrinsic CAR prior and a difference prior, with a weight pj interpreted as the
strength of support for spatial smoothing for each region:
bj = vj + pjuj + (1− pj)wj
vj ∼ N(0, σ2v)
uj|u−j ∼ N
(∑
i∼j ui
nj
,
ω2u
nj
)
w ∼ 1√
λ
exp
(
−1
λ
∑
i∼j
|wi − wj|
)
.
The choice of prior on w was intended as a proxy for measuring spatial rates of change in risk,
although the authors acknowledge that other choices, such as the raw differences. between
regions, are also possible. Note that, when pj = 1, the standard BYM model is recovered and
thus, will suffer from the same issue of non-identifiability (see previous Section). On the other
hand, as pj tends to zero, the jump component wj is favoured. In the case study provided
by Lawson and Clark (2002), this extension was shown to outperform the BYM model, as
determined by both BIC and AIC and was able to reproduce sudden jumps in observed relative
risk. As such, the authors argued that the balance this model strikes between smoothing and
jumps, and was an improvement over a single smoothing model, as is the case with the BYM
model.
5.4 Clustering-based approaches
An alternative formulation of disease mapping is to instead view each region as belonging to
one of a distinct number of categories or components, each modelled by a constant, otherwise
unobservable relative risk. Thus, the problem is reformulated into one of region classification.
Key papers adopting this approach were published be Knorr-Held and Rasser (2000), Denison
and Holmes (2001) and Green and Richardson (2002). The unifying element of these studies
was the introduction of a discrete valued, latent variable for each region, zj ∈ (1, . . . , K), to
describe the membership of region j to one of these K components. In Knorr-Held and Rasser
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(2000), the following model hierarchy was adopted for relative risk
θj = pizj
zj ∈ (1, . . . , K)
log pik ∼ N(µ, σ2); k = 1, . . . , K
K ∝ (1− c)K ; c = constant.
The constant c is either set to zero, resulting in a U(1, n) prior on the number of components or
a geometric prior for 0 < c ≤ 1, up to a multiplicative constant. An alternative interpretation
of this model is as a common random effects model, with all regions assigned to component k
sharing in common the random effect pik.
To determine the latent allocation of each region, zj, the model is initialised by selecting
1 ≤ K ≤ n regions as cluster centroids, denoted by GK = (g1, . . . , gK). The remaining n −K
regions are allocated on one of these K clusters via a distance measure d(ri, rj), defined as the
minimum number of region boundaries crossed in order to move from region i to region j. For
region i, its allocation to cluster j satisfies,
d(i, gi) ≤ d(i, gl)
l ∈ (1, . . . , K); l 6= j.
As a direct consequence of this allocation approach, identically-classified regions will be spatially
contiguous. To estimate the true number of components, a reversible jump Markov Chain Monte
Carlo (RJMCMC) scheme (Richardson and Green, 1997) was employed.
In a similar vein, Denison and Holmes (2001) proposed a clustering model based on Voronoi
tessellations (Green and Sibson, 1978), used to generate points corresponding to component
centroids. Given a set of regions with locations x = (x1, . . . ,xn), these are then allocated to the
centroid-defined clusters using the Euclidean distance, again resulting in each cluster consisting
of contiguous regions. Likening this to the approach of Knorr-Held and Rasser (2000), the true
number of tessellation points is treated as unknown and hence inferred from the data, this time
by Metropolis Hastings(Hastings, 1970). In the paper, the prior on the relative risks (pi) is
replaced by a Gamma distribution.
Differentiating itself from the above two approaches, Green and Richardson (2002) proposed
the use of a hidden Markov model (HMM), a common variant of the mixture model (Marin
et al., 2005; Fru¨hwirth-Schnatter, 2006), with spatial dependence as a solution to unsupervised
partitioning of relative risk. Their model comprised of the following hierarchy where, similar
to related modelling approaches, spatial dependence in the data is incorporated via the latent
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variable.
θj = log pizj
zj ∈ (1, . . . , K)
pik ∼ G(α, β); k = 1, . . . , K
K ∼ U(1, kmax).
The latent variable z = (z1, . . . , zn) is defined using the Potts model (Potts, 1952), resulting in
the joint density:
p(z|γ,K) = exp (γU(z)− δK(γ))
U(z) =
∑
j∼j′
I(zj = zj′)
δK(γ) = log
 ∑
z∈(1,...,K)n
exp(γU(z))
 .
Here, γ is named the interaction parameter and is non-negative such that larger values for this
parameter indicate increased spatial dependence. The interaction parameter was assigned a
discrete Uniform prior distribution, define don the range (0, 0.1, . . . , γmax). The term δK(γ)
represents the normalising constant of the Potts model to ensure that, for each region, the
probabilities of belonging to each latent component sum to one. Computation of this constant
involves the summation of all possible allocations implied by z1, . . . , zn and is computed offline
and stored prior to analysis. Similar to Knorr-Held and Rasser (2000), model estimation may
be performed using RJMCMC.
In a simulation study by Richardson et al. (2004), the performance of the BYM model described
in Section 5.1 was compared with the HMM approach of Green and Richardson (2002), with an
emphasis on estimation of the true relative risk. Overall, it was concluded that the performance
of the HMM approach was dependent upon the sufficiency of information contained in the
data. In greater detail, when the data gave moderately-sized expected counts over all regions
and/or true risks that were noticeably higher than the remaining regions, the HMM was able
to separate regions of varying relative risk well and outperformed the BYM model, with the
latter producing greater smoothing of estimates. Conversely, when the observed data did not
provide sufficient “cues” to infer discontinuities in the risk surface, the HMM produced greater
over-smoothing than the BYM model.
A closely related model based on mixtures of distributions was proposed by Ferna´ndez and
Green (2002), who considered modelling disease counts using a mixture of Poisson distribu-
tions,
p(Yj|θ, η,K) =
K∑
k=1
ηjkPo(Ejθk).
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In this instance, the latent variable was incorporated into the component weights, ηjk = Pr(zj =
k|θk), with these weights subject to the constraint
∑K
k=1 ηjk = 1 for all j. Compared to the
standard mixture model formulation, this model allowed the weights to vary over regions.
To account for spatial dependence, two proposals that accommodated for spatially correlated
weights were considered. The first proposal took the form of a logistic regression on ηjk,
ηjk =
exp {xjk/φ}∑K
l=1 exp {xjl/φ}
(13)
with xk = (x1k, . . . , xnk); k = 1, . . . , K jointly distributed according to a Markov random field
(see Ferna´ndez and Green (2002) for full details). The second proposal was described as a
grouped continuous model, with ηjk modelled by a series of functions involving cut-points over
k = 1, . . . , K, assumed unknown and thus assigned a prior distribution.
The development of models by both Ferna´ndez and Green (2002) and Green and Richardson
(2002) provided a number of key benefits over other, partition-based strategies to disease map-
ping. Firstly, the clustering of similar regions with respect to relative risk was no longer confined
to neighbouring or contiguous regions, resulting in greater model flexibility not least in terms of
better capturing discontinuties in relative risk. Secondly, by introducing a probabilistic mecha-
nism for the allocation of regions into components, uncertainty in each region’s true component
membership was naturally modelled within the Bayesian framework. Thirdly, in both studies,
comparison with the BYM model on simulated data resulted in reductions to the root averaged
mean squared error for the true relative risks in addition to improved boundary detection. In
Green and Richardson (2002), model comparison on real data using the Deviance Information
Criterion (DIC) (Spiegelhalter et al., 2002) also provided a clear indication of improved model
fit over the BYM model.
5.5 Joint modelling of multiple diseases
The models discussed thus far are univariate and therefore only capable of modelling spatial
variation in a single disease. In many cases in practice, however, it may be thought that
multiple diseases share common features, for example, lifestyle related risk factors such as diet
or smoking. As a consequence, it may make sense to model multiple diseases simultaneously,
such that one can borrow strength across both space and disease types. For the general case,
given D diseases under study, the observed data would assume the form:
Y1,j ∼ Po(E1,jθ1,j)
Y2,j ∼ Po(E2,jθ2,j)
...
YD,j ∼ Po(ED,jθD,j).
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Or, in matrix notation, for a single region Yj = (Y1,j, . . . , YD,j),
Yj ∼ Po(Ejθj)
where Ej is a diagonal matrix with entries (E1,j, . . . , ED,j) and θj = (θ1,j, . . . , θD,j) is a
D−dimensional column vector.
Early disease mapping studies that aim to model multiple diseases include those by Clayton
et al. (1993) and Bernardinelli et al. (1997), who modelled relative risks for a single disease
using information from other diseases as fixed effects, and Mollie´ (1990), who considered an
Empirical Bayes’ approach for the joint modelling of two disease that ignored spatial variation
over regions.
A selection of more recent approaches to joint disease mapping is discussed in this Section. We
first consider the multivariate extension of the CAR specification, introduced in Section 5.1.
Extending the univariate approach of Besag et al. (1991), given a collection of spatial effects
uT = (u1, . . . ,un), where each uj is a p-dimensional column vector, the full conditional for uj
in a multivariate CAR setting is given by
uj|ui 6=j,Σj ∼ ND
(∑
i
wji
nj
IDui,
Σ
nj
)
,
based on the result of Mardia (1988). Comparing this to the univariate CAR model (see
Equation (10)), the mean of each full conditional is identical; ie. when D = 1,
∑
i
wji
nj
Ipui =∑
i wjiui
nj
and therefore, the spatial smoothing properties of the BYM model are retained. It
follows then, for D > 1, the spatial dependencies modelling by the random effects are assumed
to be the same for all diseases under study. The remaining term in the multivariate CAR
- n−1j Σ - accounts for possible correlations amongst diseases, as Σ is of size D × D. If all
diseases are assumed independent a priori, Σ may set to a diagonal matrix of form σ2uID or
diag(σ21, . . . , σ
2
D). Otherwise, each element may be assumed unknown and modelled using, for
example, an Inverse Wishart distribution.
Jointly, the distribution of the spatial random effects is given by,
U|Σ ∝ exp
(
−1
2
UT ((D−W)⊗ Σ−1)U
)
(14)
where ⊗ denotes the Kronecker product. Note the use of upper case for the representation
of the random effects in Equation (14) as this joint specification requires a reordering of u to
give the row vector: U = (uT1 , . . . ,u
T
D). In shorthand, this model is denoted as MCAR(1,Σ)
(Gelfand and Vounatsou, 2003). Early accounts of the MCAR(1,Σ) model in disease mapping
studies were considered by Langford et al. (1999), who also considered modelling covariances
for the spatial random effects using distance-based measures and, in the context of survival
data, by Carlin and Banerjee (2003). As per the univariate case, however, the MCAR(1,Σ)
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model is improper, due to the singularity produced by the inverse of (D −W). A proper
model nonetheless is easily obtained, in a similar vein to the univariate case, and is denoted
by MCAR(ρ,Σ) (For full details, see Gelfand and Vounatsou (2003)). A related modelling
approach, known as the two fold CAR prior, was considered by Kim et al. (2001) where, in
place of the joint distribution for each uj, full conditional distributions of the form ujp|u−(jp), ·
were specified with the restriction D = 2. Finally, in an effort to avoid potential problems in
specifying the joint covariance matrix in the MCAR(ρ,Σ) model, Jin et al. (2005) proposed
the generalized MCAR model, of which the multivariate CAR model is a special case.
By casting the modelling of multiple diseases as a multivariate problem, the aforementioned
models focus on modelling the correlation or strength of the relationship between diseases. In
other words, a potential drawback of these models is that they do not allow for the separation
of unexplained variation into components that are common across diseases versus those that are
disease-specific. This idea of decomposition motivated the shared component model of Knorr-
Held and Best (2001) who, extending the univariate partitioning approach of Knorr-Held and
Rasser (2000), considered the modelling of two diseases using the model:
Y1,j ∼ Po(E1,jθδjφ1,j)
Y2,j ∼ Po(E2,jθ1/δj φ2,j).
Here, the shared component involves the overall relative risk for region j, θj, and is weighted by
the scalar δ, the latter referred to as the “risk gradient” when reformulated on the logarithmic
scale. The inclusion of this parameter is intended to capture differences in the magnitude of
region-specific relative risks, with δ = 1 of course corresponding to an equal overall relative risk
for both diseases. For this reason, the shared component model has also been referred to as a
single component factor model (Tzala and Best, 2007) The disease specific-components for the
jth region are then specified by the parameters φ1,j and φ2,j, that in turn inform the disease-
specific relative risk for region j and are intended as proxies for unobserved covariates specific
to each individual disease. The set of parameters (θ, φ1, φ2) are assumed independent and each
is modelled using the partitioning approach proposed by Knorr-Held and Rasser (2000).
By allowing each of these parameters its own clustering model, a number of scenarios could arise.
For example, if θj = constant for all j, this implies that there is no shared clustering behaviour
in relative risk between diseases. Consequently, unobserved spatial variation is assumed specific
to each disease, thus supposing that relative risks are independent across diseases (but not
necessarily across regions). Alternatively, if both φ1 and φ2 are constant over regions, then all
spatial clustering in relative risk is assumed to be driven by the shared component, scaled by
δ.
Taking these and other scenarios into consideration, the authors argue that the shared compo-
nent model represents a flexible modelling approach to joint disease mapping, where the data
informs on the strength of each component of relative risk. However, they also note potential
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drawbacks of this approach, including the arguable strong assumption of independence between
the shared and disease specific components, thus excluding the possibility of interaction. Fur-
thermore, Held et al. (2005) notes that, with regard to disease-specific components, vague prior
assumptions may lead to identifiability issues. To help control the number of “levels” of rela-
tive risk inferred by the partitioning mechanisms, geometric prior distributions for the chosen
partitioning algorithm are specified to penalise large numbers of partitions, in an attempt to
avoid over-fitting.
Held et al. (2005) proposed an extension to the shared component model that enabled the
joint modelling of more than two diseases. In place of a common risk gradient, this approach
considered K latent spatial factors, each common to at least two diseases, and introduced the
relative weights δkj : k = 1, . . . , K to model the extent of “sharing” of each component across
diseases. The argument behind this approach was that it allowed for different subsets of diseases
to share unobserved covariates in common, subject to spatial dependence. To demonstrate
the methodology, the authors considered a case study in modelling four diseases - oral (1),
oesophagus (2), larynx (3) and lung (4) cancer - with two unknown spatial components. This
led to the model:
log θ1j ∼ N (α1 + δ1,1u1j + δ2,1u2j, τ1)
log θ2j ∼ N (α2 + δ1,2u1j + δ2,2u2j, τ2)
log θ3j ∼ N (α3 + δ1,3u1j + δ2,3u2j, τ3)
log θ4j ∼ N (α4 + δ1,4u1j, τ4) .
In this case, the latent components were denoted by u1 and u2 and were included as proxies for
smoking; u1, common to all cancers, and alcohol consumption; u2 a risk factor common to the
first three cancers. Given the inclusion of an intercept for each individual cancer, a sum to zero
constraint was applied to each latent component. In contrast to Knorr-Held and Best (2001),
who assumed a partitioning approach for the shared component, both u1 and u2 were assigned
CAR prior distributions to describe spatial variation. By reviewing the ratios for different pairs
of δ weights, the authors were able to show the relative contributions of each common spatial
component to independent disease relative risk.
From an applied perspective, the main problem with this model is that the latent spatial com-
ponents (u1,u2) may not have an intuitive interpretation. Therefore, without direct knowledge
of key risk factors and their commonality across different diseases, this model may prove dif-
ficult to define and interpret. Furthermore, the model does not accommodate for interaction
between the latent components. Nevertheless, it provides a novel and flexible extension to the
two disease case.
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5.6 Summary of spatial models
The use of any model outlined in this review of course depends on the specific aims of the
analysis. In this Section, we provide some general guidelines that may assist the user’s choice
of modelling approach. These guidelines are formulated using a comparative approach.
Neighbourhood-based versus distance-based formulations of the spa-
tial random effects
This first choice corresponds to cases where the model chosen for the relative risks involves
spatial effects, such as the BYM model. Highlighted earlier in this review, the choice to model
these effects was between a distance-based covariance matrix, where the spatial association
between regions is modelled as a function of distance, and a neighbourhood structure, based
on regional adjacencies.
As a general rule, the neighbourhood-based approach is not recommended when the areas under
study is comprised of irregularly spaced regions, as the distance between regional centroids
may vary substantially. Furthermore, in Pascutto et al. (2000), a distance-based approach was
deemed most appropriate when select regions contain no observed data, which could arise in
cases when the area under study consists of both urban and rural areas.
The use of the neighbourhood-based CAR model, however, should not be discounted since,
from a Bayesian computational perspective, it provides a more efficient model parametrization
that avoids the costly step of matrix inversion. Thus, in cases where computational time is of
concern, the choice of a neighbourhood structure may be appealing.
The BYM model versus alternative CAR specifications
In practice, the use of an intrinsic CAR model in disease mapping does not pose complications
for model fitting and therefore, the choice of an improper versus proper prior is arguably at the
choice of the user. In fact, when the intrinsic CAR prior is chosen, Bayesian modelling software
packages such as WinBUGS (Spiegelhalter et al., 2004) automatically apply the sum to zero
constraint to remedy the impropriety of the spatial random effects.
An argument for the use of a proper CAR model is that such constraints need not be applied.
Furthermore, the added flexibility introduced by the proper CAR model is that the parameter
ρ may be interpreted as a measure of strength of spatial association Gelfand and Vounatsou
(2003) and thus allows for the possibility of spatial independence, unlike the intrinsic CAR
model. Consequently, the choice between the use of an intrinsic and proper CAR model should
also take into account the desire to infer the strength of spatial association between the regions
under study.
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Alternative CAR specifications detailed in this review should be considered in cases where one
in interested in drawing inferences about the unstructured and spatial random effects separately,
as the BYM model is well known to suffer from non-identifiability, relating to these random
effects. Note that this issue is entirely different to the concept of propriety, as the proper
CAR model does not allow for individual inferences to be drawn. An example of when these
alternate models, for example by Leroux et al. (1999) and Dean and MacNab (2001), should
be used is when we seek to formally assess the proportion of unexplained variation that is
explained by spatial clustering (Best et al., 1999) and produce uncertainty bounds around this
quantity.
CAR-based versus partition-based approaches
The description of alternatives to the BYM model in Section 5.2 introduced a separate class
of models that view disease mapping as a problem in unsupervised clustering. In their favour,
partition-based strategies to disease mapping generally result in less global smoothing of relative
risk estimates, however, as suggested by Richardson et al. (2004), this may be influenced by
the sizes of expected counts over regions. As a result, partitioning methods are more capable
of capturing discontinuities in risk between neighbouring regions. Furthermore, with particular
reference to the model proposed by Richardson and Green (1997), this partitioning model is
very flexible, as it allows for the borrowing of strength not limited to neighbouring areas (Best
et al., 2005), compared to both the BYM model and other partitioning models discussed.
A potential drawback of partition-based approaches exists when there is substantial hetero-
geneity in the observed data, particularly in the identification of moderate risk areas. In a
simulation study conducted by Best et al. (2005), the HMM of Richardson and Green (1997)
tended to produce excess partitioning of regions with low or background relative risk. Further-
more, compared to other models, it was shown to produce higher discrepancies between the
posterior and true estimates of risk for regions that exhibited properties characteristic of both
low and high relative risk regions.
Another issue worth considering when choosing between a CAR-based versus a partition-based
spatial model is computational burden. Again using the model of Richardson and Green (1997)
as an example, model computation requires the evaluation of the normalising constant in the
Potts model. While this need only be computed once and offline, the time required to complete
this evaluation may be significant and indeed exacerbated as the number of regions included
in the model increases. In contrast, the use of a CAR-based model is motivated by relative
computational efficiency and thus, this should also be considered when choosing a model for
any given study.
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6 Spatio-temporal modelling of disease risk
The implementation of spatial models for disease mapping has contributed greatly to under-
standing spatial patterns in disease risk, contributing risk factors and, from a decision making
viewpoint, the identification of regions with elevated risk, prompting further investigation. That
said, the extension of these models into the time domains presents more opprtunities for under-
standing the temporal evolution of disease, including capturing changes in the socio-economic
makeup of regions under study and providing evidence of effect following the redistribution of
resources for disease management.
Within the Bayesian framework, spatio-temporal models aim to capture not only spatial vari-
ation, but also temporal variation in relative risk and how these dimensions interact. In this
section, a review of key papers that consider spatio-temporal analyses for disease mapping are
discussed, beginning with models that extend the BYM model into the time dimension.
6.1 The BYM model revisited
In many early studies of spatio-temporal modelling, the BYM model introduced in Section 5.1
was extended in various ways to include random effects that varied over time. In this Section,
key papers that adopted this approach are reviewed in brief. While observed covariates may
be easily incorporated into any of the following models, namely
log θjt = β
Txit + bjt, (15)
for simplicity, this discussion is restricted to the specification of the (other) fixed and random
effects, bjt. The choice of form for bjt is based on assumptions regarding the relationship between
spatial and temporal random effects. Throughout this discussion, a total of T observed time
periods are assumed, such that t = 1, . . . , T .
Among the earliest studies was by Bernardinelli et al. (1995). The specification of the random
effects involved the assumption of a linear time trend, and allowed for space-time interac-
tion.
bjt = α + φj + (β + δj)t.
The models consists of an overall risk (α), a slope parameter describing the average temporal
trend (β), regional random effects (φj) and random effects to represent space-time interaction
(δj). Interpreting the random effects, φj models region j’s deviation from the overall disease rate
and δj differentiates between the overall and region-specific time trend. To ensure identifiability,
sum to zero constraints were placed on both δj and φj.
Unlike the BYM model that includes both structured and unstructured random effects, Bernar-
dinelli et al. (1995) only consider models with a single random effect. To justify this choice, the
authors argue that the inclusion of both types of random effects is unnecessary. For example,
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for data collected at a fine resolution, accounting for spatial variation may be deemed more
important than assuming lack of spatial structure in disease risk. As a result, depending on
prior belief, both φ and δ are assigned either a CAR or independent Normal prior.
The possibility of correlation between the random intercept and slope is also considered and
modelled via the conditional prior δi ∼ N(γφi, σ2). A U(−∞,+∞) prior is assigned to the
unknown parameter γ. This prior encapsulates the idea that, should correlation exist, regions
with a similar intercept will likely be modelled by a common slope.
The model considered by Bernardinelli et al. (1995) only considered a linear trend over time.
In practice, this assumption may not be justified and has thus led others to develop different
specifications for temporal variation in disease risk.
Representing an alternative approach to the problem, Waller et al. (1997) assumed the random
effects to take the form,
bjt = u
(t)
j + v
(t)
j
which was equivalent to fitting the standard BYM model to data observed at each time point
independently.
This approach permits analysis of the spatial effects and their temporal evolution however,
it should be noted that both random effects were treated as exchangeable over time. The
extension of the model to include a main effect in time (δt) was also proposed although not
applied for the featured case study. Should such an effect be included, sum to zero constraint
on v would need to be applied. Furthermore, covariates and spatio-temporal interaction were
not considered.
To resolve the need to account for temporal variation, Knorr-Held and Besag (1998) proposed
the inclusion of a temporal random effect as part of the BYM model, denoted by αt.
bjt = αt + uj + vj (16)
To account for temporal trends, αt was assigned a first order random walk prior (Besag et al.,
1995), defined by the joint density,
p(α|λα) ∝ exp
(
−λα
2
T∑
t=2
(αt − αt−1)2
)
. (17)
In essence, the above prior stipulates the belief that the effect at time t depends on the same
effect estimated for the previous time period. This prior is easily extended to temporal depen-
dencies of higher orders. Finally, the prior distributions for uj and vj remain unchanged from
the BYM model.
Knorr-Held and Besag (1998) further stratify the observed disease counts by age group and
gender×race combinations (ie. male vs. female/white vs. non-white). Therefore, additional
effects for each of these strata were included in Equation (16).
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The decomposition of the spatial and temporal effects in Equation (16) implies the effects are
additive and do not interact, therefore resulting in a perceived drawback for this model.
Proposing a more flexible approach that extends the model of Knorr-Held and Besag (1998),
Knorr-Held (2000) considered a model that permitted not only space-time interaction, but also
structured and unstructured space and time-specific random effects,
bjt = αt + γt + uj + vj + δjt.
To encode prior belief in temporal trends, the terms αt and γt represent effects for each time
period t, with and without temporal structure. Temporal structure is specified in the prior
distribution for αt, for example, as a first order random walk (Besag et al., 1995). For temporally
unstructured variation at each time point, γt is assigned an independent, zero-mean Normal
distribution.
Following the notation of Knorr-Held (2000), the prior for the joint distribution of each random
effect was re-expressed as a Multivariate Normal distribution with mean equal to zero and
precision matrix given by Σ−1 = λK. In each case, λ was a scalar and K was referred as the
structure matrix (Clayton, 1996). For example, the random walk prior on α becomes,
(α1, . . . , αT ) ∼ NT (0, λαKα)
Kα =

1 −1 0 · · · 0 0
−1 2 −1 0 · · · 0
0 −1 2 −1 · · · 0
...
...
...
. . .
...
...
0 · · · 0 −1 2 −1
0 · · · · · · 0 −1 1

.
This reparameterisation for each effect was then useful for modelling space-time interaction of
different forms, via the term δjt. Specifically, four types of space-time interaction were possible
using this model, depending on the a priori assumptions of the nature of the interaction. Each
of these interactions is described in Table 1.
Spatial effect Temporal effect Interpretation of
(j) (t) space-time interaction (δjt)
γ v Interaction in unobserved covariates
independent in space and time
α v Different regions exhibit their own temporal trend;
not influenced by neighbouring regions
γ u Spatial effects are expected to vary independent of time
α u Regions exhibit different time trends;
trends are influenced by neighbouring regions
Table 1: Different types of spatio-temporal interaction as specified by Knorr-Held (2000)
24
Depending on the terms included in the interaction, the joint distribution of δ is modelled by
a Multivariate Normal with precision matrix λδKδ, where Kδ is set to the Kronecker product
of structure matrices of each individual effect (Clayton, 1996). For example, when temporal
trends vary between regions, but are not considered to be spatially related, δjt = αt × vj and
δ ∼ NnT (0, λδKδ) where,
Kδ =

K
(1,1)
α Kv · · · K(1,T )α Kv
K
(2,1)
α Kv · · · K(2,T )α Kv
...
. . .
...
K
(T,1)
α Ku · · · K(T,T )α Kv

with Ki,j referring to the (i, j) element of K.
6.2 Dynamic linear models
The use of Dynamic linear models (see West and Harrison (1997)), also referred to in the litera-
ture as state-space models, provide an alternative parametrisation for capturing temporal effects
in disease mapping. Briefly, a dynamic linear model consists of an observation equation
log θt = Ftβt + vt
vt ∼ N(0, σ2In) (18)
and a transition equation
βt = Gtβt−1 + ut
ut ∼ N(0,Σ). (19)
Beginning with the observation equation (Equation (18)), the aim is to estimate the log rela-
tive risks for each region, for each observed time period; ie. θt = (θ1,t, . . . , θn,t). Unstructured
variation attributed to each time period is absorbed into the term vt = (v1t, . . . , vnt). Con-
versely, in Equation (19), temporal trends are incorporated into the prediction of log relative
risk through the unknown regression coefficients at time t, βt. These covariates may include
either an overall time effect, in a similar vein to some BYM-based models described earlier, or
sets of explanatory variables collected for each region. Spatial smoothing is also incorporated
into this transition or update equation, achieved through ut = (u1t, . . . , unt), for example, by
specifying Σ to give a CAR prior. Thus, the use of a dynamic linear model accommodates time
varying effects through a first-order random walk. Finally, the vectors Ft Gt, known as system
matrices, is set to reflect relationships between log θt and βt, in addition to βt and βt−1. These
matrices are specified depending on the nature of the problem and modelling assumptions but,
in many cases, are set to the identity matrix.
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The dynamic linear model is thus reminiscent of the BYM models of Waller et al. (1997) and
Knorr-Held and Besag (1998). For the former, both structured and unstructured extra-Poisson
variation is estimated for each time point. However, similar to Knorr-Held and Besag (1998),
an overall temporal effect is also accounted for.
A recent application of a dynamic linear model for disease mapping, given areal data, was
considered by Schmidt et al. (2010), with an application in mapping malaria incidence rates in
municipalities in the Amazon rainforest. In this study, malaria counts for twelve municipalities
were collected every four months from January 1999 to December 2002. Spatial correlation be-
tween monitored regions was captured using a free-form Inverse Wishart distribution, marking
a departure from the usual CAR model approach. The novelty of their study was the predic-
tion of malaria incidence for unobserved regions/municipalities, for example, in very remote
or inaccessible regions of the rainforest. In Lopes et al. (2008) and Strickland et al. (2011),
the dynamic linear model framework was adopted for the development of a spatial dynamic
factor model. Briefly, for a single time period, a common trends and cycles model is adopted
for yt = (y1t, . . . , ynt), to give
yt = Bµµt +Bψψt + t
t ∼ N(0, diag(σ21, . . . , σ2n)).
The matrices Bµ and Bψ represent factor loading matrices for the common trends (µt), mod-
elled by a multivariate random walk, and common cycles (ψt), assumed to follow a first-order
autoregressive process. When the factor loadings are combined into a block matrix, spatial
dependence is modelled between factor loadings using a Gaussian random field (Lopes et al.,
2008) or a first order intrinsic CAR prior (Strickland et al., 2011).
6.3 Nonparametric approaches
6.3.1 Generalised additive mixed models
In some cases, the underlying spatio-temporal structure of disease risk may be too complicated
to suffice its summary by a single, parametric trend, for instance, by a linear temporal trend
as was the case in Waller et al. (1997). Instead, one may prefer to fit more complex temporal
trends, to be learned from the data.
Generalised additive mixed models (GAMMs) are an extension of the Generlised Linear Mixed
model (GLMM), of which the BYM model is an example. At the heart of GAMMs is the use of
splines, a general term describing the class of smooth, piecewise polynomials. Given observed
data over a defined time period, the use of splines aims to capture complicated temporal trends,
unable to be sufficiently summarised by a single parametric function. By specifying a number
of “knots”, a spline will fit a polynomial of order D to each interval, with boundaries defined
by successive knots and assumed to be equally spaced. Mathematically, a spline for modelling
26
a temporal trend would be represented as
S(t) =
K∑
k=1
βkpk(t) (20)
where the sequence of constants (β1, . . . , βK) is unknown and pk(t) is the k
th spline basis func-
tion, evaluated at time t. These basis functions correspond to the local, piecewise polynomial
trends and are estimated from the observed data in each interval. The total number of basis
functions, K, depends on the degree of the polynomial fitted to each interval and the number
of knots specified. Most commonly, cubic splines are used, meaning that K = L + 3. Other
common examples of basis functions in penalised splines and smoothing splines (see De Boor
(2001)).
To exemplify the utility of splines in capturing complex temporal behaviour, Figure 3 illustrates
a simulated dataset over a ten time periods. In the top plot, it is clear that a simple linear
trend is insufficient for fully explaining the variation in the observed data. Conversely, in the
next two plots, the use of splines with different numbers of knots appears to be more successful
in explaining the dynamics of the data.
Figure 3: Example of fitting splines to data observed over time. The top plot shows the fit
achieved assuming a linear trend and the bottom two plots show fits produced by cubic splines
with different numbers of knots.
In disease mapping, the use of GAMMs is a relatively new innovation in methodology. Examples
of their use include studies by MacNab (2001), MacNab (2007) and MacNab and Gustafson
(2007). In each of these cases, splines for different temporal trends were investigated and
different choices for the basis functions were compared. For example, in MacNab (2001), cubic
splines were considered in the first instance for the overall (fixed) temporal trend, with a linear
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temporal trend assumed for each region, defined by unknown parameters βj.
log θjt = logm+ αj + S0(t) + βj × t
S0(t) =
4∑
k=1
β0,kpk(t).
To capture spatial correlation amongst regions, the region spatial effect α = (α1, . . . , αn) was
assigned a CAR prior. The remaining term (logm) was included as a fixed effect, representing
the overall relative risk across regions and time periods. To increase flexibility, the second
model considered also contained splines for the random temporal effects, to allow for regional
variation.
log θjt = logm+ αj + S0(t) + Sr(t)
Sr(t) =
4∑
k=1
βr,kpk(t).
Both models were applied to a case study for infant mortality in British Columbia, Canada.
Depending on the data under study, a potential drawback specific to GAMMs is choosing the
most appropriate number of knots to describe the observed data. In the aforementioned studies
in disease mapping, this issue was considered as a task in model selection. Briefly, by fitting
models with successive numbers of knots, a goodness of fit criterion was used to compare the
relative fits of each model, resulting in the choice of a model with the “best” number of knots
to describe trends in the data. This process may prove cumbersome, particularly when large
numbers of time periods and/or large numbers of regions are under consideration. Furthermore,
in the cited studies, when splines were used to model both fixed and random temporal effects,
the number of knots was assumed equal for each effect. Anecdotally, there may exist cases where
the most appropriate number of knots may differ between fixed and random effects.
6.3.2 Dirichlet Process Mixture models
Kottas et al. (2007) proposed a Dirichlet Process Mixture (DPM) model for spatio-temporal
modelling of disease incidence data, with an application to lung cancer in Ohio over the period
1968 − 1988. Compared to other methods already considered in the report, a DPM may be
likened to partitioning-based methods presented in Section 5.2. In this case, focus is placed
on grouping time periods with similar spatial random effects, where the total number of these
unobservable groups or components is unknown. Unlike the methods of estimation used in
Section 5.2, the total number of components may be countable infinite, meaning that there is
no need to specify a maximum allowable number of components, kmax.
The basic concept behind a DPM is as follows. Suppose for the first time period, the observed
data is modelled spatially by random effects u1. These random effects are then representative
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of the first DPM component. For the second time period, its spatial random effects may either
be modelled by u1, with some defined probability, or by a new set of random effects, u2,
resulting in the generation of a new component. It follows then that each new time period
will be modelled by spatial random effects already estimated for a previous time period or
periods, with a probability proportional to the number of time periods assigned to each realised
component, or will produce a new component with new spatial random effects. The definition of
assignment probabilities in this way produces a clustering effect, whereby there is also a non-zero
probability of generating a new component to account for dynamic changes in spatial variation.
The partitioning of random effects in this way is often referred to as a Chinese restaurant
process, providing a useful visualisation for understanding the rationale behind DPMs.
Figure 4 provides an example of the Dirichlet process as a prior distribution for random effects
over ten time periods. In this case we see that periods 1 and 2 are modelled by the same
random effects, however for the next three consecutive periods, the is a defined change in u.
For the sixth and seventh periods, we see a reverting back to the random effects equalling u1
before another change is inferred for periods 8 through to 10.
u1 u3 u8u2
u6
u7
u4
u5
u9
u10
Figure 4: An example of clustering in spatial random effects for ten consecutive time periods
Turning to the spatial DP approach by Kottas et al. (2007), their first model considered the
partitioning of spatial effects without concern for temporal dependence. In the sequel, temporal
correlation in the spatial random effects was formally taken into account through the introduc-
tion of a state space model (West and Harrison, 1997) on ut. This involved the specification of
the random walk:
ut = νut−1 + ηt
with |ν| < 1 and the DP instead being place on the innovation term ηt.
6.4 Multiple disease modelling in space and time
As with spatial-only analyses of disease risk, it is often logical to map multiple diseases simulta-
neously, such that information is not only shared over space and time but also between related
diseases. Best described as an extension of the shared component model by Knorr-Held and
Best (2001), Richardson et al. (2006) proposed a model for the spatio-temporal modelling of
lung cancer incidence. In this case, multiple diseases was taken as disease risk in male and
female subpopulations. Of the four variants of model proposed, the simplest modelled relative
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risk for each gender in the following manner:
log θ1jt = δuj + κwt (21)
log θ2jt =
uj
δ
+
wt
κ
+ βj + γt (22)
where θ1jt is the relative risk for males in region j at time t and θ2jt is similarly defined for
females.
In Equation (22), βj represents the difference in spatial patterns between gender and γt defines
the temporal difference. In both Equations (21) and (22), we see that relative risk is modelled
by both a common spatial (uj) and temporal (wt) trend, adjusted by a risk gradient for each
dimension (δ for space and κ for time). Another way of interpreting these gradients is as the
relative effects of the common factors on their contribution to relative risk between males and
females. For Bayesian estimation, CAR priors were placed on u, w, β and γ. As a brief aside,
the CAR model for temporal correlation involves the specification of a neighbourhood matrix
of size T × T whereby wij = 1 if time periods i and j are adjacent and zero otherwise. This
specification is equivalent to a first order random walk prior. Variants of this base model in-
clude the inclusion of space-time interaction, achieved by adding the term νjt to each relative
risk equation, and the inclusion of gender-specific heterogeneity terms, intended to capture any
remaining unobserved variation not described by spatial and temporal trends, and their inter-
action. In the discussion of their paper, Richardson et al. (2006) note that a useful extension
to this model may be the inclusion of observed covariates for estimated the common spatial
and temporal components.
For more than two diseases or outcomes of interest, Tzala and Best (2007) considered a latent
factor model for spatio-temporal modelling of multiple diseases, with a case study in cancer risk
in Greece. Again given D diseases under study, indexed by d, each relative risk was assumed
to follow the distribution
log θdjt ∼ N
(
µdjt, σ
2
d
)
(23)
such that σ2d represented disease-specific, extra Poisson variation. The motivation behind the
use of factor analysis was to investigate the presence of any common, otherwise unobservable
spatial and temporal patterns across all diseases. These latent variables or “factors” were
thus interpreted as unobserved covariates common to all diseases under study, inferred from
spatio-temporal relationships specified by the chosen prior distributions.
The proposed factor analysis was incorporated via the term µdjt with three specifications con-
sidered, discussed briefly here. In the simplest case, relative risk was modelling using a single
common factor, assumed exchangeable in space and time, resulting in the model,
µdjt = βdxjt + λdfjt. (24)
Here, the common factor is defined by fjt, with λd corresponding to the disease-specific factor
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loading. The implied exchangeability in fjt means that any common temporal trends are allowed
to vary between locations, and vice versa. However, in its current form, the above model is
unable to capture any spatial and/or temporal relationships, for any disease. Nevertheless, this
model also allows for the inclusion of region and time-specific covariates, with the associated
regression parameters (βd) permitted to vary across diseases. For example, in the case study by
Tzala and Best (2007), the log SMR for lung cancer was included as a covariate and represented
a proxy for smoking, as it was known covariate common to all cancers being investigated.
To account for any further unexplained variation associated with disease d, the second model
studied included disease-specific residuals in both space (sdj) and time (tdt):
µdjt = βdxjt + λdfjt + sdj + tdt. (25)
Both the priors for sd = (sd1, . . . , sdn) and td = (td1, . . . , tdT ) are formulated to express spatial
and temporal correlation, namely via the specification of CAR priors. The interpretation of the
common factor in Equation (25) remains unchanged and thus, for both models, fjt is assigned
a standard Normal prior (ie. fjt ∼ N(0, 1)).
For the final model, the common factor is decomposed in a common spatial factor and a
common temporal factor. This meant one was now able to model both spatial and temporal
trends common to all diseases, with the following model specification.
µdjt = βdxjt + λ
s
df
s
j + λ
t
df
t
t + sdj + tdt. (26)
Common spatial and temporal associations were incorporated by assigning CAR priors to both
f s and f t with the conditional variance for both priors constrained to equal one, to ensure factor
identifiability. Beyond its ability to model more than two diseases in space and time simultane-
ously, this factor model does not accommodate common factors for explaining spatio-temporal
interaction. Furthermore, to enable identifiability of both common factors, the constraints used
must be considered carefully and may not be obvious in all cases.
7 Summary of spatio-temporal models
Similar to Section 5.4, a practical summary is provided in this Section for purposes of choosing
a spatio-temporal modelling approach, depending on the aims of the study. This Section begins
by comparing the features of the different spatio-temporal extensions of the BYM model, before
comparing parametric versus nonparametric approaches.
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Choosing between different BYM model extensions
The review of extensions to the spatial-only BYM model revealed that model choice within this
class should be determined by (i) how one wishes to model temporal trends and (ii) whether
or not one is interested in accounting for spatio-temporal interaction.
Of the models reviewed, the approach of Knorr-Held (2000) provides the most general approach
to spatio-temporal modelling. In his paper Knorr-Held (2000) points out that, depending on
the aims of analysis and assumptions concerning spatio-temporal interaction, random effects
may be omitted as required. Thus, it could be said that the model of Knorr-Held (2000) is a
generalisation of most BYM-related approaches in Section 6.1.
In cases where spatio-temporal interaction is not thought to exist, the approaches of Waller
et al. (1997) and Knorr-Held and Besag (1998) present possible approaches for modelling dis-
ease risk in space and time. That said, these three models make different assumption about
temporal trends and therefore presents another consideration regarding model choice. In Waller
et al. (1997), random effects are estimated for each observed time period and therefore, suffers
from the drawback that correlation between successive time periods is not taken into account.
Conversely, whilst an overall temporal trend is explicitly modelled by Knorr-Held and Besag
(1998), the unstructured and spatially structured random effects are assumed constant over all
time periods. Consequently, this model treats extra Poisson variation as either due to purely
spatial or purely temporal trends. In practice, an alternative compromise would be the com-
bination of these two modelling approaches, as is provided through the use of dynamic linear
models, discussed briefly in Section 6.2.
For models that account for spatio-temporal interaction, when the overall temporal trend in
risk is assumed to be monotone, the model of Bernardinelli et al. (1995) presents a simple
to implement approach. Furthermore, it encapsulates the natural property that regions with
similar regional random effects will tend to exhibit the same trend over time. However, as
mentioned previously in the discussion of this model, this assumption is rarely tenable in
practice. As a result, an exploratory analysis of the data, including plots of temporal trends
over all regions, should be conducted prior to choosing this model.
When such an overall temporal trend does not exist, the model of Knorr-Held (2000) provides
the most general approach to spatio-temporal modelling. In his paper Knorr-Held (2000)
points out that, depending on the aims of analysis and assumptions concerning spatio-temporal
interaction, random effects may be omitted as required. Furthermore, its specification of spatio-
temporal interaction allows it to also be removed, should belief dictate that this interaction
does not exist. Thus, it could be said that the model of Knorr-Held (2000) is a generalisation
of all BYM-related approaches in Section 6.1, excluding Waller et al. (1997).
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Parametric versus nonparametric approaches
The use of nonparametric methods, described in Section 6.3, arguably provide the user with
more flexible approaches to modelling complex temporal and spatial trends in disease mapping.
For GAMMs, the class of models based on splines, their key benefit is the ability to model more
complicated trend in time, both overall and for each individual region. Conversely, the DPM
model allows for the parsimonious modelling of time-varying spatial random effects, whereby
time periods with similar random effects are clustered with one another, as opposed to modelling
these effect separately for each time period.
For GAMMs, a potential drawback of their use over parametric methods (see Sections 6.1 and
6.2), is that they do not exhibit the same “sharing of information” as would be the case BYM-
based models. For example, in the study by MacNab (2001), whilst the introduction of splines
for regional variation allowed one to model region-specific temporal trends, the specification
of spline coefficients for each region (βrk) meant that these were estimated for each region
indenpendently. As such, the model was not as parsimonious as the BYM models that allowed
for similar trends to “share” parameters. Furthermore, from a computational perspective, the
choice of the most appropriate number of knots was also highlighted as a potential drawback
and therefore, compared to parametric methods, the application of splines could prove more
cumbersome.
DPM models, on the other hand, represent a parsimonious approache to modelling, and cap-
turing changes in, unobserved spatial variation, in light of its partition-based approach, similar
to methods described in Section 5.2. However, of all the models presented in this review,
DPMs are arugably the most computationally expensive and therefore, this should be taken
into consideration when choosing a model for analysis.
8 Contributions to project aims
By conducting a review of existing approaches to disease mapping, we aim to identify the most
appropriate modelling strategies for providing detailed analyses on single and multiple cancer
incidence and mortality. On the broader scale, the results of these analysis facilitate the con-
struction of more detailed maps of cancer risk estimates, uncertainty attached to these estimates
and ultimately, the identification of regions of greatest perceived need for resources.
The inclusion of measured covariates into these models may also allow for greater understanding
of the demographic and socio-economic drivers of cancer, leading to the identification of region
of elevated relative risk. The ability to identify such areas contributes substantially to the
aims of this project, as it may assist and inform the decisions of governments and other related
bodies in the effective and efficient allocation of resources. Furthermore, the availability of
region-specific covariate information on resources may also enhance our understanding of risk
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and could greatly assist us in judging the utility of the current state of resources.
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